Nebula Research & Development’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-31,781
| Closed | -$2.65M | – | 1185 |
|
|
2024
Q4 | $2.65M | Buy |
31,781
+9,740
| +44% | +$813K | 0.31% | 64 |
|
|
2024
Q3 | $1.61M | Sell |
22,041
-11,631
| -35% | -$851K | 0.19% | 137 |
|
|
2024
Q2 | $2.31M | Buy |
+33,672
| New | +$2.31M | 0.37% | 32 |
|
|
2024
Q1 | – | Sell |
-8,631
| Closed | -$618K | – | 1033 |
|
|
2023
Q4 | $618K | Buy |
8,631
+2,166
| +34% | +$155K | 0.19% | 184 |
|
|
2023
Q3 | $337K | Buy |
+6,465
| New | +$337K | 0.18% | 240 |
|
|
2023
Q2 | – | Sell |
-3,960
| Closed | -$214K | – | 465 |
|
|
2023
Q1 | $214K | Buy |
+3,960
| New | +$214K | 0.38% | 167 |
|